Drugs for Neglected Diseases Initiative DNDi

Mission

We, at the Drugs for Neglected Diseases initiative (DNDi), are committed to discovering, developing and delivering safe, effective, affordable treatments for children and adults affected by devastating neglected diseases. Since 2003, DNDi has developed 13 new treatments for six deadly diseases, saving millions of lives. Our work focuses on devastating neglected diseases and other infectious diseases affecting neglected populations where we can have the most impact. We were founded in 2003 by the medical humanitarian organization Doctors Without Borders after they dedicated a portion of their Nobel Peace Prize award to exploring a new, alternative, not-for-profit model for developing drugs for neglected patients

Vision

DNDi’s vision is to develop new drugs or new formulations of existing drugs for patients suffering f

Goals

1.the development of drugs for the most neglected diseases, such as sleeping sickness, leishmaniasis, and Chagas disease; and it will also consider engaging R&D projects on other neglected diseases
2.DNDi will address unmet needs by taking on projects that others are unable or unwilling to pursue and, as means permit, will consider development of diagnostics and/or vaccines.
3.While using the existing support capacities in countries where the diseases are endemic, we will help build additional capacity through technology transfer in drug R&D for neglected diseases

New York NY | EIN: 20-8774179

Profile managed by nonprofit | Is this your nonprofit?

501(c)(3) organization

40 Rector Street, 16th Floor,
New York NY 10006

https://www.dndina.org/

646-215-7076

Drugs for Neglected Diseases Initiative DNDi

Mission

Vision

DNDi’s vision is to develop new drugs or new formulations of existing drugs for patients suffering f

Goals

1.the development of drugs for the most neglected diseases, such as sleeping sickness, leishmaniasis, and Chagas disease; and it will also consider engaging R&D projects on other neglected diseases
2.DNDi will address unmet needs by taking on projects that others are unable or unwilling to pursue and, as means permit, will consider development of diagnostics and/or vaccines.
3.While using the existing support capacities in countries where the diseases are endemic, we will help build additional capacity through technology transfer in drug R&D for neglected diseases

New York NY | EIN: 20-8774179

Profile managed by nonprofit | Is this your nonprofit?

501(c)(3) organization

40 Rector Street, 16th Floor,
New York NY 10006

https://www.dndina.org/

646-215-7076

Beacon Report

Great
Good
Needs Improvement
Poor
Not Scored
Additional Information

Website Reported on Tax Form:Yes

SCORE100%

No Material Diversion of Assets:Yes

SCORE100%

Financial Statements:Yes

SCORE100%

Audit Oversight Committee:Yes

SCORE100%

No Loans Reported To or From Officers:Yes

SCORE100%

Records Retention Policy:No

SCORE0%

Tax Form Disclosed on Website:Yes

SCORE100%

Accountability Panel
Score	Metric
100%	Website Reported on Tax Form:Yes
100%	No Material Diversion of Assets:Yes
100%	Financial Statements:Yes
100%	Audit Oversight Committee:Yes
100%	No Loans Reported To or From Officers:Yes
0%	Records Retention Policy:No
100%	Tax Form Disclosed on Website:Yes

Science behind the numbers

Error attempting donation

You're too fast!

Mission

Mission

Beacon Report